CDKN2A and ovarian serous carcinoma: There are several studies showing that p16 is overexpressed in high-grade serous ovarian carcinoma compared with other morphologic types of ovarian cancer [33], whereas inactivation of the gene was observed in 3 out of 9 endometrioid and 1 out of 4 clear cell ovarian carcinomas [34].